[1] LIU X J, GUO B, LI Q Y, et al. mTOR in metabolic homeostasis and disease[J]. Exp Cell Res, 2024, 441(2): 114173. doi:  10.1016/j.yexcr.2024.114173
[2] AKDAĞ N, ATLI E, ZHURI D, et al. A Study of FoxO1, mTOR, miR-21, miR-29b, and miR-98 Expression Levels Regarding Metabolic Syndrome in Acne Vulgaris Patients[J]. Cureus, 2024, 16(3): e56562. doi:  10.7759/cureus.56562
[3] KIM H J, KIM Y H. Exploring acne treatments: from pathophysiological mechanisms to emerging therapies[J]. Int J Mol Sci, 2024, 25(10): 5302. doi:  10.3390/ijms25105302
[4] MELNIK B C. Acne transcriptomics: fundamentals of acne pathogenesis and isotretinoin treatment[J]. Cells, 2023, 12(22): 2600. doi:  10.3390/cells12222600
[5] BEN-AMITAI D, LARON Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne[J]. J Eur Acad Dermatol Venereol, 2011, 25(8): 950-954. doi:  10.1111/j.1468-3083.2010.03896.x
[6] MELNIK B C. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update[J]. Clin Cosmet Investig Dermatol, 2015, 8: 371-388. doi:  10.2147/ccid.s69135
[7] GU H, AN H J, GWON M G, et al. Bee venom and its major component melittin attenuated Cutibacterium acnes- and IGF-1-induced acne vulgaris via inactivation of Akt/mTOR/SREBP signaling pathway[J]. Int J Mol Sci, 2022, 23(6): 3152. doi:  10.3390/ijms23063152
[8] OKORO O E, CAMERA E, FLORI E, et al. Insulin and the sebaceous gland function[J]. Front Physiol, 2023, 14: 1252972. doi:  10.3389/fphys.2023.1252972
[9] OTTAVIANI M, FLORI E, MASTROFRANCESCO A, et al. Sebocyte differentiation as a new target for acne therapy: an in vivo experience[J]. J Eur Acad Dermatol Venereol, 2020, 34(8): 1803-1814. doi:  10.1111/jdv.16252
[10] GRUSZCZYŃSKA M, SADOWSKA-PRZYTOCKA A, SZYBIAK W, et al. Insulin resistance in patients with acne vulgaris[J]. Biomedicines, 2023, 11(8): 2294. doi:  10.3390/biomedicines11082294
[11] PANWAR V, SINGH A, BHATT M, et al. Multifaceted role of mTOR(mammalian target of rapamycin)signaling pathway in human health and disease[J]. Signal Transduct Target Ther, 2023, 8(1): 375.
[12] GU H, AN H J, GWON M G, et al. The effects of synthetic SREBP-1 and PPAR-γ decoy oligodeoxynucleotide on acne-like disease in vivo and in vitro via lipogenic regulation[J]. Biomolecules, 2022, 12(12): 1858. doi:  10.3390/biom12121858
[13] CAO K, LIU Y, LIANG N N, et al. Fatty acid profiling in facial sebum and erythrocytes from adult patients with moderate acne[J]. Front Physiol, 2022, 13: 921866. doi:  10.3389/fphys.2022.921866
[14] MOON K M, LEE M K, HWANG T, et al. The multi-functional roles of forkhead box protein O in skin aging and diseases[J]. Redox Biol, 2021, 46: 102101. doi:  10.1016/j.redox.2021.102101
[15] RYGUŁA I, PIKIEWICZ W, KAMINIÓW K. Impact of diet and nutrition in patients with acne vulgaris[J]. Nutrients, 2024, 16(10): 1476. doi:  10.3390/nu16101476
[16] IM M, KIM S Y, SOHN K C, et al. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes[J]. J Invest Dermatol, 2012, 132(12): 2700-2708. doi:  10.1038/jid.2012.202
[17] BALDWIN H, TAN J. Effects of diet on acne and its response to treatment[J]. Am J Clin Dermatol, 2021, 22(1): 55-65. doi:  10.1007/s40257-020-00542-y
[18] GOUL C, PERUZZO R, ZONCU R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease[J]. Nat Rev Mol Cell Biol, 2023, 24(12): 857-875. doi:  10.1038/s41580-023-00641-8
[19] POLIDORI N, GRASSO E A, CHIARELLI F, et al. Amino acid-related metabolic signature in obese children and adolescents[J]. Nutrients, 2022, 14(7): 1454. doi:  10.3390/nu14071454
[20] YOSHIMURA R, NOMURA S. Co-ingestion of glutamine and leucine synergistically promotes mTORC1 activation[J]. Sci Rep, 2022, 12(1): 15870. doi:  10.1038/s41598-022-20251-2
[21] DOWNIE M T, KEALEY T. Human sebaceous glands engage in aerobic glycolysis and glutaminolysis[J]. Br J Dermatol, 2004, 151(2): 320-327. doi:  10.1111/j.1365-2133.2004.06004.x
[22] HU T T, WEI Z Y, JU Q, et al. Sex hormones and acne: state of the art[J]. J Dtsch Dermatol Ges, 2021, 19(4): 509-515. doi:  10.1111/ddg.14426
[23] GRATTON R, DEL VECCHIO C, ZUPIN L, et al. Unraveling the role of sex hormones on keratinocyte functions in human inflammatory skin diseases[J]. Int J Mol Sci, 2022, 23(6): 3132. doi:  10.3390/ijms23063132
[24] SZEFLER L, SZYBIAK-SKORA W, SADOWSKA-PRZYTOCKA A, et al. Metformin therapy for acne vulgaris: a meta-analysis[J]. Pharmaceuticals, 2024, 17(6): 728.
[25] VAN ALLER G S, CARSON J D, TANG W, et al. Epigallocatechin gallate(EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor[J]. Biochem Biophys Res Commun, 2011, 406(2): 194-199.
[26] YOON J Y, KWON H H, MIN S U, et al. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes[J]. J Invest Dermatol, 2013, 133(2): 429-440. doi:  10.1038/jid.2012.292
[27] WEI Z Y, CHEN G J, HU T T, et al. Resveratrol ameliorates lipid accumulation and inflammation in human SZ95 sebocytes via the AMPK signaling pathways in vitro[J]. J Dermatol Sci, 2021, 103(3): 156-166. doi:  10.1016/j.jdermsci.2021.07.010
[28] LIU S, LUO X H, LIU Y F, et al. Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes[J]. Sci Rep, 2023, 13(1): 21576. doi:  10.1038/s41598-023-48709-x
[29] LUO J, HE W Y, LI X, et al. Anti-acne vulgaris effects of chlorogenic acid by anti-inflammatory activity and lipogenesis inhibition[J]. Exp Dermatol, 2021, 30(6): 865-871. doi:  10.1111/exd.14277
[30] JIN S, LEE M Y. The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes[J]. PLoS One, 2018, 13(8): e0202933. doi:  10.1371/journal.pone.0202933
[31] HWANG Y L, IM M, LEE M H, et al. Inhibitory effect of imperatorin on insulin-like growth factor-1-induced sebum production in human sebocytes cultured in vitro[J]. Life Sci, 2016, 144: 49-53. doi:  10.1016/j.lfs.2015.11.027
[32] WANG C, HWANG Y L, LI X M, et al. Inhibition of insulin-like growth factor-1-induced sebum production by bilobetin in cultured human sebocytes[J]. Ann Dermatol, 2019, 31(3): 294-299. doi:  10.5021/ad.2019.31.3.294
[33] SUH Y, YANG J H, YOON J Y, et al. Platycodin D may improve acne and prevent scarring by downregulating SREBP-1 expression via inhibition of IGF-1R/PI3K/Akt pathway and modulating inflammation with an increase in collagen[J]. Ann Dermatol, 2018, 30(5): 581-587. doi:  10.5021/ad.2018.30.5.581
[34] KWON H H, YOON J Y, PARK S Y, et al. Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne[J]. J Invest Dermatol, 2015, 135(6): 1491-1500. doi:  10.1038/jid.2015.29